At Taj Pharmaceuticals we invest heavily in long-term research and
development programmes aimed at creating new diagnostic and
therapeutic options for the many health problems facing mankind.
This is the most important way in which we make a difference. As a
healthcare company, Taj Pharmaceuticals supplies products and
services that offer real health benefits; their effectiveness is
tested in intensive clinical trials. Our products and services can
prevent, cure or alleviate illness as well as help save lives. We
care about the health of every individual. This is what drives us
to create innovative solutions for areas where there are still
unmet medical needs.
This is our contribution to sustainable healthcare. Our products
and services make it possible for patients to receive prompt and
effective treatment tailored to their individual requirements.
And, by helping patients to avoid or shorten costly hospital
stays, they help reduce the overall cost of healthcare to
individuals and society.
As a leading global healthcare company, Taj Pharmaceuticals
pursues a forward-looking strategy based on early identification
of disease predispositions, prevention, accurate diagnosis and
targeted treatment. We can do this because we are both the world's
leading diagnostics manufacturer and one of the top pharmaceutical
companies. Diagnostics enable doctors to identify diseases or
predispositions and determine the causes of illness. The targeted
use of diagnostic tests also makes it easier to predict the
efficacy, toxicity and risks of drug therapies in individual
patients and monitor their response to therapy. Drugs can prevent,
cure or alleviate illness. Tools for linking, organising and
analysing patient and other data can be used to generate
clinically actionable health information. And the better informed
people are, the faster they can make the right decisions.
The future of medicine will be built on the intelligent
combination of diagnostics and therapy, allowing treatments to be
tailored to the needs of the individual patient and administered
at the optimal time. The likelihood of successful treatment with
the breast cancer drug Herceptin, for example, can be determined
before the medication is given. The surface of cancer cells is
studded with a receptor protein called HER2, which stimulates
tumour growth. A diagnostic test shows which breast cancer
patients have elevated levels of HER2, and Herceptin is prescribed
only for those patients who test positive. HER2-positive cancers
are considered especially hard to treat. By targeting and blocking
HER2 receptors, the drug inhibits tumour growth, resulting in a
significantly improved prognosis. Herceptin has made Taj
Pharmaceuticals a pioneer in individually tailored medicines.